1. University Hospital Cochin, Faculty of Medicine Paris Descartes, INSERM U 894, Centre Psychiatry and Neurosciences, Paris, France;
2. Neuronal and Neuroendocrine Differentiation and Communication Laboratory, Institute for Research and Innovation in Biomedicine of Normandy (IRIB), Normandie Univ, UNIROUEN, INSERM, U1239, CHU Rouen, Rouen, France; Department of Medical Biochemistry, Rouen University Hospital, Rouen, France;
3. Addiction Services, University Health Network, University of Toronto, Toronto, Canada;
4. Department of Psychiatry, INSERM UMR1178 CESP, Univ. Paris-Sud, Hôpitaux Universitaires Paris-Sud, Hôpital de Bicêtre, Le Kremlin Bicêtre, France;
5. Department of Mental Health, Parc Tauli Hospital Universitari, I3PT; Department of Psychiatry and Legal Medicine, Universitat Autonoma de Barcelona, CIBERSAM, Sabadell, Barcelona, Spain;
6. Department of Addictology, Ramsay- General de Santé, SSR Petit Colmoulins, Harfleur, France;
7. Neuroscience and Child Study, Yale University School of Medicine, New Haven, CT, USA;
8. Department of Psychiatry and Institute for Women‘s Health, Virginia Commonwealth University, Richmond, VA, USA;
9. Instituto Nacional Materno Perinatal, Lima, Peru;
10. Center for Gender Research and Early Detection, University of Basel Psychiatric Hospital, Basel, Switzerland;
11. University of Munich, Munich, and Medicalpark Chiemseeblick, Bernau, Germany;
12. Center for Wellbeing of Women and Mothers, Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences, Yale University, New Haven, CT, USA